Monserrat Llaguno‐Munive

Author

Instituto Nacional de Cancerología ORCID

Also Known As

M. Llaguno-Munive, Monserrat Llaguno, Monserrat Llaguno Munive, Monserrat Llaguno-Munive, Monserrat Llaguno‐Munive

Publications

248

Citations

H-Index

Concepts

All Affiliations

Instituto Nacional de Cancerología Universidad Nacional Autónoma de México Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine Vall d'Hebron Hospital Universitari Vall d'Hebron Institut de Recerca

About

Monserrat Llaguno‐Munive is an author at Instituto Nacional de Cancerología specializing in radiation oncology, engineering, and nanomedicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	2	2	44
2	Medicine	2	2	34
3	Biomedical Engineering	2	2	44
4	Pharmacology	2	2	34
5	Cell Biology	1	1	16

Monserrat Llaguno‐Munive

Publications

166

Citations

H-Index

Page 1

	Year	Citations
Smart and eco-friendly N-isopropylacrylamide and cellulose hydrogels as a safe dual-drug local cancer therapy approach Fernanda Andrade, María Mercé Roca-Melendres, Monserrat Llaguno‐Munive, Carbohydrate Polymers Biopolymer GelHydrogelsNanomedicineEngineeringPolymer-drug Conjugate	2022	26
Mifepristone as a Potential Therapy to Reduce Angiogenesis and P-Glycoprotein Associated With Glioblastoma Resistance to Temozolomide Monserrat Llaguno‐Munive, Sebastián León-Zetina, Inés Vázquez‐López, Frontiers in Oncology	2020	24
Mifepristone Overcomes Tumor Resistance to Temozolomide Associated with DNA Damage Repair and Apoptosis in an Orthotopic Model of Glioblastoma Monserrat Llaguno‐Munive, Mario Romero-Piña, Janeth Serrano‐Bello, Cancers	2018	23
Mifepristone improves chemo-radiation response in glioblastoma xenografts Monserrat Llaguno‐Munive, Luis A. Medina, Rafael Jurado, Cancer Cell International	2013	18
Preparation and Evaluation of Mebendazole Microemulsion for Intranasal Delivery: an Alternative Approach for Glioblastoma Treatment Julio Mena-Hernández, Helgi Jung–Cook, Monserrat Llaguno‐Munive, AAPS PharmSciTech Cell-based Drug DeliveryNanomedicineNeuro-oncologyEngineeringIntranasal Delivery	2020	18
Preclinical Development of Magnetic Nanoparticles for Hyperthermia Treatment of Pancreatic Cancer Zamira V. Díaz‐Riascos, Monserrat Llaguno‐Munive, Nuria Lafuente‐Gómez, ACS Applied Materials & Interfaces	2025	17
Ketoconazole Reverses Imatinib Resistance in Human Chronic Myelogenous Leukemia K562 Cells Omar Prado-Carrillo, Abner Arenas-Ramírez, Monserrat Llaguno‐Munive, International Journal of Molecular Sciences Hematological MalignancyChromatinChronic Myeloid LeukemiaCml ChemotherapyOncology	2022	16
SFRP1 increases TMPRSS2-ERG expression promoting neoplastic features in prostate cancer in vitro and in vivo Carlos D. Cruz-Hernández, Marian Cruz-Burgos, Sergio A. Cortés-Ramírez, Cancer Cell International	2020	13
Intracellular Delivery of Anti-Kirsten Rat Sarcoma Antibodies Mediated by Polymeric Micelles Exerts Strong <i>In Vitro</i> and <i>In Vivo</i> Anti-Tumorigenic Activity in Kirsten Rat Sarcoma-Mutated Cancers Diana Rafael, Sara Montero‐Herradón, Pilar Carcavilla, ACS Applied Materials & Interfaces	2023	11

Page 1